Polaroid Therapeutics completes pre-clinical milestones in the development of superior antimicrobial technology for acute and chronic wounds

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Polaroid-Therapuetics

More Like This

PR Newswire associated0

MolecuLight Announces Groundbreaking Study on Antimicrobial Stewardship in Wound Care

New report from Access to Medicine Foundation shows what pharma companies can do to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance

PR Newswire associated0

Latest Clinical Evidence Presented at APWCA's Wound Week™ 2023 Illustrates the Significant and New Clinical Utility of the MolecuLight Point-of-Care Imaging Platform

PR Newswire associated0

Pioneering Innovation from MolecuLight Earns Best Abstract at SAWC Spring 2024

Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd

Business Wire logo

Debiopharm Underlines Commitment to Eradicating Antimicrobial Resistance by Sponsoring the 8th Annual World AMR Conference

PR Newswire associated0

MolecuLight's Profound Impact on Wound Healing Highlighted in Breaking Clinical Research

MolecuLight Clinical Research Featured at the Upcoming SAWC Spring 2024 Conference